15 Aug Patients with CLL Should Be Monitored for Skin Cancer, Including Melanoma
MedicalResearch.com Interview with:
Clive S. Zent MD
Professor of Medicine
Director of Lymphoma/CLL Program
Wilmot Cancer Institute
University of Rochester Medical Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) have an increased risk of all skin cancers including malignant melanoma.
This study in a stable population of CLL patients managed by a regional referral center confirmed that melanoma was over 6 times more common in than in an age and sexed matched general population. Because of the proactive skin screening program at the University of Rochester Medical Center’s Wilmot Cancer Center, most melanomas (77%) were detected at earlier stages and were treated surgically with curative intent. One patient with CLL and metastatic melanoma had a sustained remission of both diseases on treatment with ibrutinib and pembrolizumab.MedicalResearch.com: What should readers take away from your report?
Response: Patients with CLL should be actively monitored for skin cancers with regular self-examinations and dermatology follow up. Early detection of melanoma can result in curative management.
MedicalResearch.com: What recommendations do you have for future research as a result of this work?
Response: Determine the causes for increased risk of skin cancer in patients with CLL.
William J. Archibald, Philip J. Meacham, AnnaLynn M. Williams, Andrea M. Baran, Adrienne I. Victor, Paul M. Barr, Deepak M. Sahasrahbudhe, Clive S. Zent. Management of melanoma in patients with chronic lymphocytic leukemia. Leukemia Research, 2018; 71: 43 DOI: 10.1016/j.leukres.2018.07.003
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on August 15, 2018 by Marie Benz MD FAAD